NCT06416891View on ClinicalTrials.gov

Effect of Adding Dexamethasone to Bupivacaine 0.25% in SCPB on Surgical Field Visibility During Tympanomastoid Surgery

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

July 15, 2024

Conditions
Surgical FieldPostoperative Pain
Interventions
DRUG

bupivacaine 0.25%

SCPB using 10 ml of bupivacaine 0.25%

DRUG

dexamethasone 2 mg in bupivacaine 0.25%

SCPB using dexamethasone 2 mg in 10 ml of bupivacaine 0.25%

Trial Locations (1)

Unknown

Faculty of Medicine, Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT06416891 - Effect of Adding Dexamethasone to Bupivacaine 0.25% in SCPB on Surgical Field Visibility During Tympanomastoid Surgery | Biotech Hunter | Biotech Hunter